SCHEMBL8811250

SCHEMBL8811250

COc1ccc(C(Cl)CCCC=O)c(OC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
HTT P42858 1/20 0.40
APLNR P35414 1/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA12 O43570 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CYP1A1 P04798 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP1B1 Q16678 1/20 0.38
MAPT P10636 2/20 0.37
MAPK1 P28482 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
LY96 Q9Y6Y9 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA1A P35348 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8810946 0.86 TRPV4 (0.38) ALDH1A1HTTMEN1KMT2A
SCHEMBL8813933 0.82 TP53 (0.39) HTTCA1CA2CA12CA7
SCHEMBL8812936 0.82 ALDH1A1 (0.37) ALDH1A1CA1CA2CA12CA9
SCHEMBL8809472 0.81 ERN1 (0.37) ALDH1A1APLNRCYP1A1CYP1A2CYP1B1
SCHEMBL8811978 0.78 GAA (0.39) ALDH1A1TDP1L3MBTL1HSD17B10CYP3A4
SCHEMBL8811038 0.78 ABCB11 (0.46) CYP1A2MAPTTDP1L3MBTL1
SCHEMBL8809338 0.78 ERN1 (0.39) ALDH1A1HTTMAPTL3MBTL1MEN1
SCHEMBL8812013 0.77 TTR (0.41) ALDH1A1HTTADRA2AADRA1AMEN1
SCHEMBL8811667 0.74 TSHR (0.39) ALDH1A1HTTCYP1A2MAPTMAPK1
SCHEMBL8809704 0.74 CTSA (0.42) ALDH1A1MAPTTDP1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997000872-A1 1,3,8-TRIAZA- AND 3,8-DIAZA-1-OXASPIRO(4,5)DECANE DERIVATIVES F.HOFFMANN-LA ROCHE AG (CH) 1997-01-09 WO disclosed